Convergence Investment Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.29M	Buy	159,769 +4,650	+3%	+$37.6K	0.33%	106
2025 Q1	$1.3M	Sell	155,119 -52,890	-25%	-$443K	0.36%	92
2024 Q4	$1.65M	Buy	208,009 +41,161	+25%	+$326K	0.37%	97
2024 Q3	$1.39M	Buy	166,848 +23,633	+17%	+$197K	0.37%	89
2024 Q2	$909K	Buy	+143,215	New	+$909K	0.27%	121